StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Stock Down 28.0 % CFRX opened at $0.05 on Friday. The company has a market cap of $535,000.00, a price-to-earnings ratio of 0.00 and a beta […]
StockNews.com began coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance ContraFect stock opened at $0.05 on Friday. The stock has a market capitalization of $535,000.00, a price-to-earnings ratio of 0.00 and a […]
StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report released on Saturday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Performance Shares of NASDAQ CFRX opened at $0.05 on Friday. The firm has a market cap of $535,000.00, a P/E ratio of 0.00 and a […]
StockNews.com began coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research note published on Thursday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Performance CFRX stock opened at $0.05 on Thursday. ContraFect has a fifty-two week low of $0.04 and a fifty-two week high of $13.02. The […]
StockNews.com initiated coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Trading Down 28.0 % Shares of NASDAQ:CFRX opened at $0.05 on Thursday. ContraFect has a 12-month low of $0.04 and a 12-month high […]